Serious riskFDA DrugClass I

UMARY hyaluronic acid supplement recalled for undeclared drugs

FDA laboratory analysis found the UMARY Acido Hialuronico supplement contains undeclared dexamethasone, diclofenac and omeprazole, which are not listed on the label. The product was also marketed without an approved NDA or ANDA. About 15 bottles were distributed nationwide under the IBeautiStore.com brand.

From the FDA notice · Read the official notice ↗

What to do

  1. Stop using the product and don't give it to others.
  2. Check whether your bottle is labeled "UMARY Acido Hialuronico" or "New Hyaluronic Acid 850mg Sealed 30 Caps" with 30 capsules of 850 mg.
  3. The notice doesn't say how to get a refund or replacement; contact IBeautiStore.com or where you bought it.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
UMARY Acido Hialuronico, also known as: "New Hyaluronic Acid 850mg Sealed 30 Caps", Suplemento Alimenticio, Contenido Neto: 30 capletas de 850 mg.
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
15 bottles
Illnesses reported
None reported
Manufactured in
3042 Route 22 # 38, Dover Plains, New York, United States
Classification
Class I
Recall number
D-0189-2027

In the FDA's words

Description
UMARY Acido Hialuronico, also known as: "New Hyaluronic Acid 850mg Sealed 30 Caps", Suplemento Alimenticio, Contenido Neto: 30 capletas de 850 mg. Marketed without approved NDA/ANDA- FDA laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole. Lots 241209P3, 250129P3, 250508P3, 25112P3 & 260511P3, any Expiration Date between 9/26 and 8/28. Distribution: USA Nationwide Affected quantity: 15 bottles
Hazard
Marketed without approved NDA/ANDA- FDA laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole.

Related topics